99results about How to "Good duration" patented technology

This invention relates to Factor VIII muteins that are covalently bound, at one or more predefined sites that are not an N-terminal amine, to one or more biocompatible polymers such as polyethylene glycol. The mutein conjugates retain FVIII procoagulant activity, are capable of correcting human factor VIII deficiencies and have improved pharmacokinetic properties.

The addition of DMD illumination modulator(s) 702 in series with projection SLM(s) 706 / 709 to produce high-performance projection displays with improved optical efficiency, reliability, and lower maintenance requirements. This approach eliminates the vibration, audible noise, and safety problems associated with high speed rotating color filter wheels 203 commonly used in SLM projectors and controls the light applied to individual areas of the projection SLM(s).

A method of UV curing and corresponding resulting non-polymeric cross-linked gel are provided. The cross-linked gel can be combined with a medical device structure. The cross-linked gel can provide anti-adhesion characteristics, in addition to improved healing and anti-inflammatory response. The cross-linked gel is generally formed of a naturally occurring oil, or an oil composition formed in part of a naturally occurring oil, that is at least partially cured forming a cross-linked gel derived from at least one fatty acid compound. In addition, the oil composition can include a therapeutic agent component, such as a drug or other bioactive agent. The curing method can vary the application of UV light in both intensity and duration to achieve a desired amount of cross-linking forming the gel.

A visible light communication (VLC) receiver captures frames of a scene with a camera to detect flashing light signals from a VLC transmitter such as an array of LEDs. The method assembles an enhanced dynamic range image sequence from the frames. At least one VLC source is detected in the enhanced sequence, wherein the source occupies a respective subwindow within the scene. An imaging exposure such as the exposure time used for capturing images at the subwindow is optimized according to a brightness of the respective VLC source. Then a plurality of subwindow images are captured using the optimized exposure. VLC data visible in the subwindow images is then decoded.

Inhalation solutions for administration of muscarinic antagonists for the treatment of breathing disorders, such as COPD, are provided.

A personal computing device comprising: a processor, an onboard memory, an accelerometer, a gyroscope, and a display; a computer program to create an exercise analysis application comprising: a software module configured to receive data from the accelerometer and the gyroscope that are associated with the bodily motion of a user in three dimensions; a software module configured to place the device in a learning mode, the learning mode comprising recording the data of the user performing a defined exercise to generate a statistical model for the exercise; a software module configured to place the device in a normal mode, the normal mode comprising applying a probabilistic analysis to the bodily motion data to identify an exercise event, classify the exercise by comparison to a recorded model; and a software module configured to apply an analysis to the bodily motion data to score the user's exercise form.

A treat dispensing pet toy is shaped and weighted to remain in a normally upright position to dispense treats when contacted by an animal during interaction with the toy. The pet toy has a dome shaped base and a ring or donut-shaped cover connected to the base. A treat dispensing port is arranged on an inside circumferential edge of the cover. A central opening of the cover exposes a feeding tray. The feeding tray and inside circumferential edge define a partially enclosed area to function as a feeding bowl. Edible treats are loaded inside the cover. As the animal contacts the toy, treats are moved within the cover and pass through the dispensing port onto the feeding tray. A diverter disposed within the cover facilitates movement of the treats for easier dispensing of the treats onto the feeding tray. A method includes use of the pet toy to dispense treats.

The invention provides bacillus thuringiensis wettable powder containing pullulan polysaccharide and a preparation method thereof, relating to powder and a preparation method thereof. The invention solves the problems that the quality guarantee period and the valid period of the powder active ingredients prepared by the traditional technology are short, and the preparation process is single and dated. The bacillus thuringiensis wettable powder containing pullulan polysaccharide of the invention comprises a spore and parasporal crystal mixture, a carrier, a wetting agent and a dispersing agent. The preparation method comprises the steps of: (1) preparing seed bacteria liquid; (2) fermenting and cultivating the seed bacteria liquid to obtain fermentation liquid; (3) concentrating the fermentation liquid to obtain spore and parasporal crystal; (4) adding the carrier and NaCl to the spore and parasporal crystal mixture and blending uniformly; and (5) adding the wetting agent and the dispersing agent, blending uniformly, drying and grinding to obtain the bacillus thuringiensis wettable powder containing pullulan polysaccharide. The bacillus thuringiensis in the powder obtained in the invention has high activity, long quality guarantee period and valid period, and can be widely applied to the field of pest control in the field.

The present invention has its object to provide a medical adhesive excellent in safety, reactivity (curing rate) and duration of adhesive strength. A medical adhesive of the present invention comprises a hydrophilic urethane prepolymer (UP) obtained by reacting a fluorine-containing nonaromatic polyisocyanate component (A) and a polyol component (B) having a hydrophilic polyol (B1) as the essential component, and a phenolic radical scavenger (PRS). The content of (PRS) is preferably 0.01 to 3% by weight based on the weight of (UP). The content of oxyethylene groups in (B) is preferably 30 to 100% by weight based on the weight of the oxyalkylene groups in (B). Preferably, (B) is a mixture of a random copolymer obtained by addition of ethylene oxide and propylene oxide to diols and polypropylene glycol. The content of isocyanate groups in the medical adhesive is 1 to 10% by weight based on the weight of (UP). The medical adhesive of the present invention is suitable for bonding body tissues, such as lung, artery and heart in particular.

The invention relates to a bactericide and an application method thereof. The bactericide contains azoxystrobin and prochloraz as effective ingredient by mass percents of 30 to 1% and of 1 to 30% respectively, with the balance as auxiliary ingredients for pesticide preparation, and the proportion of the azoxystrobin to the prochloraz is 30:1 to 1:30. The complex bactericide according to the invention has wide antibacterial spectrum, strong systemic property, good quick effectiveness, long effective period and great environmental friendliness, and is favorable for reducing using time of pesticide and lowering environmental pollution as well as for integrated control, thus the bactericide is a perfect medicament in pollution-free control.

An electroless palladium plating solution is capable of forming a pure palladium plating film directly on an electroless nickel plating film without (pre)treatment such as substituted palladium plating treatment or the like, which pure palladium plating film has good adhesion and small variations in plating film thickness. An electroless palladium plating solution includes: a first complexing agent, a second complexing agent, phosphoric acid or a phosphate, sulfuric acid or a sulfate, and formic acid or a formate: the first complexing agent being an organopalladium complex having ethylenediamine as a ligand: the second complexing agent being a chelating agent having a carboxyl group or a salt thereof and / or a water-soluble aliphatic organic acid or a salt thereof.

The invention discloses a sterilization composite containing pyraclostrobin and propineb and a preparation method and applications thereof. The sterilization composite is characterized by containing the pyraclostrobin, the propineb and other assistants, wherein the weight ratio of the pyraclostrobin to the propineb is (1:80)-(50:9). The sterilization composite can be applied to controlling the diseases of cereals, fruit trees, melons, vegetables and the like. The composite has a wide application range, low cost and a good effect. Proved by indoor efficacy trials, the composite has an obvious synergistic effect. Moreover, blending the pyraclostrobin with the propineb is not reported yet at home and abroad, therefore, the invention is disclosed.

A system for delivering a growth hormone releasing peptide including a peptide, or a pharmaceutically acceptable salt form thereof, alternatively conjugated to a polymer via a biodegradable bond and dissolved in a liquid medium. Because extra-cellular fluids in vivo provide the appropriate environment to efficiently degrade peptides, the growth hormone releasing peptide will maintain chemical integrity and remain substantially coupled to the polymer while circulating through the body. The therapeutic agent is, therefore, protected from degradation and clearance.